A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a human monoclonal antibody, REGN2222, for the prevention of medically attended RSV infection in
12/23/2015 - 06/17/2017 (PI)Regeneron Pharmaceuticals, Inc.
A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents
10/01/2003 - 12/31/2016 (PI)Merck & Company, Inc.
A phase II, observer-blind, randomized, controlled, multi-centre study to evaluate the immunogenicity and safety of GSK Biologicals quadrivalent influenza vaccine candidate
10/23/2013 - 09/30/2016 (PI)GlaxoSmithKline LLC
A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX New Seed Process (NSP) Administered Concomitantly with M-M-R II
08/04/2014 - 08/03/2016 (PI)Merck, Sharp & Dohme LLC
A phase IIIb, open, randomized, controlled, multicenter study to assess the co-administration of Rotarix (GlaxoSmithKline Biologicals') with Hib-MenCY-TT
07/01/2013 - 06/30/2016 (PI)GlaxoSmithKline LLC
A phase IIIA, randomized, observer-blind, controlled, multinational study to evaluate the safety and immunogenicity of GSK Biologicals' MMR vaccine (209762)
08/15/2014 - 07/31/2015 (PI)GlaxoSmithKline LLC
A phase IIIA, blinded randomized controlled multinational consistency study to evaluate the immunogenicity and safety of GSK Biologicals' MMR Vaccine (209762) compared to Merck's
10/01/2012 - 06/30/2015 (PI)GlaxoSmithKline LLC
Immunogenicity and Safety of GSK Biologicals' Combined Measles-Mumps-Rubella Vaccine in Subjects Four to Six Years of Age
07/01/2012 - 06/30/2015 (PI)GlaxoSmithKline LLC
A Phase III Double blind, randomized, multicenter, controlled study to evaluate the safety, tolerability and immunogenicity of measles, mumps, rubella, varicella (MMRV) vaccine made with an alternativ
07/01/2012 - 06/30/2015 (PI)Merck & Company, Inc.
A Phase 3, Open-label, Randomized, Parallel-group, Multi-center Study to Evaluate the Safety and Immunogenecity of Novartis Meningococcal ACWY Conugate Vaccine when Administered with Routine Infant Va
11/19/2008 - 11/18/2013 (PI)Novartis Vaccines and Diagnostics, Inc.
Showing 10 of 45 results.
Show All Results